In protective effects, a decrease in IL‐22 may be considered a risk factor for type 2 diabetes and could worsen hepatitis.8, 9 However, in other diseases, IL‐22 could be pathogenic. This evidence concerns the gene IL22 and hepatitis A virus infection.